2017 Press Releases

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
DateTitle 
12/04/17NantHealth to Support the University of California San Francisco in Research Initiative Focused on Metastatic Breast Cancer
NantHealth will provide GPS Cancer molecular analysis to help UCSF better understand the molecular basis of metastatic breast cancer in order to develop personalized therapy for individual patients CULVER CITY, Calif.--(BUSINESS WIRE)--Dec. 4, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced its support for a research study initiated by the University of Califor... 
Printer Friendly Version
11/15/17NantHealth Ranked Number 304 Fastest Growing Company in North America on Deloitte’s 2017 Technology Fast 500™
Company attributes 276 percent revenue growth in 2017 to GPS Cancer™ and advanced oncology solutions CULVER CITY, Calif.--(BUSINESS WIRE)--Nov. 15, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, announced today a ranking of 304 on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in ... 
Printer Friendly Version
11/09/17NantHealth Reports 2017 Third Quarter Financial Results; GPS Revenue Doubles from Preceding Quarter
GPS Revenue Exceeds $1.0 Million in Q3, Up 128% from Q2 547 GPS Commercial Tests Ordered in Q3, Up 44% from Q2 204 GPS Tests Ordered in October, Largest Month of Orders to Date Signed New International Reseller, Expanding Global Coverage to Select Southeast Asia Markets Executed on Sale of Provider/Patient Engageme... 
Printer Friendly Version
11/03/17NantHealth to Report 2017 Third-Quarter Financial Results and Host Conference Call on Thursday, November 9
CULVER CITY, Calif.--(BUSINESS WIRE)--Nov. 3, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2017 third quarter on Thursday, November 9, 2017, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance. The conference call will... 
Printer Friendly Version
10/25/17NantHealth’s Vitality Mobile App Now Available on Apple and Android Devices
Vitality® GlowCap®, an industry leading smart pill bottle, has been proven to be effective for improving medication adherence BOSTON--(BUSINESS WIRE)--Oct. 25, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that its Vitality Mobile app is now available for download through the Apple and Google Play Stores. When linked with Vitality GlowCap, Vitality Mobile del... 
Printer Friendly Version
08/30/17NantHealth and Asia Genomics Announce Global Expansion of GPS CancerTM in Southeast Asia
Partnership enables oncologists in Singapore, Malaysia, Thailand, Vietnam and The Philippines to offer patients a new standard of care through GPS Cancer NantHealth expands global GPS Cancer launch with test now also internationally available in Israel, Mexico, Italy and the Middle East CULVER CITY, Calif. & SINGAPORE--(BUSINESS WIRE)--Aug. 30, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, announced that it has ente... 
Printer Friendly Version
08/10/17NantHealth Reports 2017 Second Quarter Financial Results; Implements Plan to Focus on Core Competencies, Enhance Profitability and Position for Growth of Artificial Intelligence for Cancer Care
Restructuring Plan Implemented To Focus on Cancer Decision Support and Artificial Intelligence Platform Integration of Four Pillars: GPS Cancer, Eviti Clinical Decision Support, Connected Care and Provider/Payer Engagement Sale of Patient/Provider Portal to Allscripts Expected to Significantly Accelerate Timeline to Profitability ... 
Printer Friendly Version
08/08/17NantHealth to Report 2017 Second-Quarter Financial Results and Host Conference Call on Thursday, August 10
CULVER CITY, Calif.--(BUSINESS WIRE)--Aug. 8, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2017 second quarter on Thursday, August 10, 2017, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance. The conference call will... 
Printer Friendly Version
08/07/17NantHealth Continues Global Expansion of GPS Cancer™ by Bringing Advanced Genomic Profiling to Patients in Mexico
Sistemas Medicos Nacionales becomes first international payer to cover GPS Cancer™ for patients, bringing a new standard of cancer care to Mexico CULVER CITY, Calif.--(BUSINESS WIRE)--Aug. 7, 2017-- NantHealth, Inc. (Nasdaq: NH), a leading next-generation, evidence-based, personalized healthcare company, today announced that GPS Cancer, a molecular test that helps guide cancer treatment strategies including choice of standard chemothera... 
Printer Friendly Version
08/01/17NantHealth Announces Three-Year Contract Extension with Long-Time Client Blue Cross and Blue Shield of Nebraska
Major commercial insurer renews contract of NaviNet Open and adds NantHealth’s Document Exchange solution to their rolodex CULVER CITY, Calif.--(BUSINESS WIRE)--Aug. 1, 2017-- NantHealth, Inc.(NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, announced today that Blue Cross and Blue Shield of Nebraska (BCBSNE),a NantHealth client since 2010, and the largest commercial insurer in the state of Nebraska, has ... 
Printer Friendly Version
06/02/17NantHealth to Present at the Jefferies Healthcare Conference on June 7, 2017
CULVER CITY, Calif.--(BUSINESS WIRE)--Jun. 2, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, announced today that the company will present at the Jefferies Healthcare Conference at 4 p.m. ET, on Wednesday, June 7, 2017 at the Grand Hyatt hotel, New York City. The company also said that Patrick Soon-Shiong, M.D., chief executive officer and chairman of NantHealth, has been invited to pa... 
Printer Friendly Version
05/23/17NantHealth Names Ronald A. Louks as Chief Operating Officer
CULVER CITY, Calif.--(BUSINESS WIRE)--May 23, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced the appointment of Ronald A. Louks as its Chief Operating Officer. “Ron brings senior level leadership and excellent experience, gained at some of the most highly regarded and well recognized companies in the world, including Blackberry, HTC and Sony Ericsson,” said Patrick ... 
Printer Friendly Version
05/10/17NantHealth Reports 16% Increase in 2017 First Quarter Total Net Revenue; SaaS Revenue Rose 11% and GPS Adoption Continues to Climb
GPS Adoption: GPS Cancer Test to Be Complementary Diagnostic for FDA Authorized Nant Cancer Vaccine Clinical Trials, the First Novel Combination of Innate and Adaptive Immunotherapy in Patients with Pancreatic Cancer 365 GPS Commercial Tests Ordered in Q1, Up from 326 in Q4 ‘16 266 GPS Commercial Tests Delivered in Q1, Up from 233 in Q4 ‘16 ... 
Printer Friendly Version
05/10/17NantHealth Appoints Dr. Sandeep Reddy as Chief Medical Officer
Company adds established oncology expert to leadership team CULVER CITY, Calif.--(BUSINESS WIRE)--May 10, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, announced today the appointment of Sandeep (Bobby) Reddy, MD, as Chief Medical Officer. In his new position, Dr. Reddy will be responsible for overseeing education, outreach, clinical development programs, and clinical trials for GP... 
Printer Friendly Version
05/08/17NantHealth to Report 2017 First-Quarter Financial Results and Host Conference Call on Wednesday, May 10
CULVER CITY, Calif.--(BUSINESS WIRE)--May 8, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2017 first quarter on Wednesday, May 10, 2017, after market close. NantHealth management will host a conference call that same day at 2 p.m. PT (5 p.m. ET) to review the company’s performance. The conference call will be availa... 
Printer Friendly Version
05/03/17NantHealth to Present at the Deutsche Bank 42nd Annual HealthCare Conference on May 4, 2017
CULVER CITY, Calif.--(BUSINESS WIRE)--May 3, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, announced today that the company will present at the Deutsche Bank 42nd Annual Health Care Conference at 10:40 a.m. ET, on Thursday, May 4, 2017 at the InterContinental Boston Hotel. The company also said that Robert Watson, who will present on behalf of NantHealth at the Deutsche conference, is... 
Printer Friendly Version
03/30/17NantHealth Reports 72% Increase in Full Year 2016 Total Net Revenue to $100 Million With SaaS Revenue Increasing More Than 181% and Increasing GPS Cancer Adoption
GPS Cancer Adoption by Oncologists Increased in Q4: 264 Oncologists Ordered 1,286 GPS Commercial & Research Tests YTD, with 452 tests in Q4, of which 326 Commercial and 126 Research First Consecutive 100 GPS Cancer Tests Completed at a Single Academic Institution (Feb-Nov 2016) Demonstrating Significant Increase in Identification of an FDA Approved Drug or Clinical Trial for Patients with Refractory... 
Printer Friendly Version
03/28/17NantHealth to Report 2016 Fourth-Quarter, Full-Year Financial Results and Host Conference Call on Thursday, March 30
CULVER CITY, Calif.--(BUSINESS WIRE)--Mar. 28, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2016 fourth quarter and full year on Thursday, March 30, 2017, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance. The confer... 
Printer Friendly Version
03/10/17NantHealth’s GPS Cancer™ Receives Support from the International Association of Fire Fighters in an Effort to Combat Job-Related Cancer
Innovative technology will provide unparalleled insights into cancer tumors, enabling personalized cancer treatment strategies for fire fighters, a population whose risk of death from cancer is significantly higher than the general population CULVER CITY, Calif.--(BUSINESS WIRE)--Mar. 10, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, announced today that the International As... 
Printer Friendly Version
03/06/17Patrick Soon-Shiong, MD, Honored with Intelligent Health Association Special Recognition Award at Nations Largest Health IT Conference
Patrick Soon-Shiong, MD, Honored with Intelligent Health Association Special Recognition Award at Nations Largest Health IT Conference March 06, 2017 05:00 AM Eastern Standard Time CULVER CITY, Calif.--(BUSINESS WIRE)--Patrick Soon-Shiong, MD, CEO and founder of NantHealth, has been awarded the Intelligent Health Association (IHA) Special Recognition Award. The award recognizes his leadership in the healthcare technology community and his commitment to transforming cancer care through per... 
Printer Friendly Version
03/01/17NantHealth to Present at the Cowen and Company 37th Annual Health Care Conference On March 7
CULVER CITY, Calif.--(BUSINESS WIRE)--Mar. 1, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that the company will present at the Cowen and Company 37th Annual Health Care Conference on Tuesday, March 7, 2017, at 9:20 a.m. ET at the Boston Marriott Copley Place hotel. An audio-only webcast of the presentation will be available at www.NantHealth.com. Listeners are... 
Printer Friendly Version
02/20/17NantHealth to Showcase New Oncology Solution Suite, Advanced Medication Adherance Solution and the Latest in Device Connectivity at HIMSS 2017 Annual Conference
Products transform the way critical diseases like cancer are known and treated NantHealth to exhibit in booth #5561 and provide live demos on the Interoperability Showcase™ Floor ORLANDO, Fla.--(BUSINESS WIRE)--Feb. 20, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, announced today that it will be exhibiting its new suite of oncology solutions at booth #5561 and provi... 
Printer Friendly Version